Cefuroxime Use in Pregnancy
Cefuroxime (cefuroxime axetil) is considered acceptable for use during pregnancy when clinically indicated. Data from published epidemiologic studies, case series, and case reports over several decades have not identified an association between cephalosporin use (including cefuroxime) during pregnancy and major birth defects, miscarriage, or adverse maternal or fetal outcomes. [1]
Teratogenicity and Pregnancy Outcome Data
Human data in multiple observational datasets have not shown an increased risk of major birth defects or miscarriage with cephalosporin exposure, including cefuroxime. [1] The FDA label states that available studies cannot definitively establish absence of risk due to methodological limitations. [1]
Dosing Considerations for Pregnancy
Cefuroxime labeling provides pregnancy risk information for use of cefuroxime axetil, including during organogenesis. [1] The safety assessment in the pregnancy section is not limited to a specific dosing schedule such as 500 mg twice daily, so safety is based on drug class exposure evidence plus the drug’s reproductive-development data rather than a pregnancy-specific endorsement of a particular dose-frequency. [1]
Indications Where Cefuroxime Is Typically Used
Cefuroxime is used as an antibiotic for bacterial infections when the organism is susceptible and the prescribed regimen is appropriate for the infection being treated. [1] Pregnancy management should align with the infection type and culture or susceptibility data when available. [1]
Monitoring and Safety Checks During Treatment
Allergy history should be reviewed for prior hypersensitivity reactions to cephalosporins and related beta-lactam antibiotics before use. [1] Clinical response to antibiotic therapy should be monitored, with reassessment if symptoms do not improve or worsen. [1]
Key Counseling Points
Cephalosporin use during pregnancy has not been associated with measurable increases in major birth defects or miscarriage in published data. [1] Unnecessary antibiotic use should be avoided because antibiotic therapy should be based on a proven or strongly suspected bacterial infection. [1]
Lactation After Delivery (If Relevant)
Cefuroxime is excreted into human milk, but estimated infant exposure from maternal use is low based on limited case reports. [1]
Practical Clinical Bottom Line for 500 mg Twice Daily
Cefuroxime 500 mg twice daily is generally compatible with pregnancy when prescribed for a susceptible bacterial infection and when no contraindicating allergy exists. [1]